Bain Capital Life Sciences Opportunities III, LP - 31 Dec 2025 SCHEDULE 13G/A Report for KYVERNA THERAPEUTICS, INC. Common Stock, $0.00001 par value per share (KYTX)

Filing Manager: Bain Capital Life Sciences Opportunities III, LP
Reporting Manager: Bain Capital Life Sciences Opportunities III, LP
Security: KYVERNA THERAPEUTICS, INC. Common Stock, $0.00001 par value per share
Symbol: KYTX
Shares outstanding: 57,592,593 shares
Disclosed Ownership: 3,110,000 shares
Ownership: 5.4%
Form type: SCHEDULE 13G/A
Filing time: 17 Feb 2026, 16:30:03 UTC
Date of event: 31 Dec 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Bain Capital Life Sciences Opportunities III, LP	5.4%	3,110,000	0	3,110,000	/s/ Adam Koppel	Adam Koppel, Partner of Bain Capital Life Sciences Investors, LLC